Anthrax Shortage

[Guest guest]

http://www.cnn.com/2000/US/07/10/anthrax.shortage.02/index.html

Pentagon to limit anthrax shots in face of vaccine shortage

July 10, 2000

Web posted at: 5:42 p.m. EDT (2142 GMT)

WASHINGTON (CNN) -- Facing a severe shortage of anthrax vaccine, the

Pentagon has decided to limit inoculations to a small number of troops most

at risk from the deadly biological agent.

" We have reached a point where we can't continue the program at its present

pace, " said Marine Maj. Gen. Randy West, a senior adviser to the deputy

defense secretary on chemical and biological protection.

The shortage has been caused by a delay in getting a new manufacturer of the

vaccine up and running. Additionally, the Food and Drug Administration has

not certified older doses of the vaccine as safe and effective.

Anthrax:

A naturally occurring bacterium found in domesticated animals, anthrax can

be produced as dry spores that, when inhaled, bring coma and death within a

few days.

Spores of anthrax are colorless, odorless and tasteless. They can be

released into the air in clouds that infect the lungs. Once contracted,

anthrax is about 99 percent fatal.

MESSAGE BOARD

The U.S. military

This week the Pentagon learned that another 200,000 doses failed the FDA

certification process because of " invalid " test results from live animal

tests of the vaccine's potency.

That batch can be retested, but that will take another month, West said. " We

won't use a single dose until we know that it's sterile, that it's pure, and

that it's potent, " he said.

West said the Pentagon now has only about 160,000 doses on hand that have

been certified as safe and effective by the FDA. That is roughly about two

months' supply at the current vaccination rate of about 75,000 shots a

month.

" Because of a shortage of supply, we are going to have to slow down the

program temporarily, " West said. " We're not going to stop. We're not going

to suspend. We are going to continue vaccinating personnel going into high

threat areas to provide them the protection that they need. "

The Pentagon could not say how many troops would receive vaccinations or

booster shots under the revised, more limited program.

So far the Pentagon has given 1.8 million shots to some 455,000 active-duty

and reserve troops since anthrax vaccinations began in 1998.

According to the Pentagon, 848 people have reported " adverse reactions " to

the shots, and in 443 cases the reactions were judged to have been related

to the vaccine.

Of those 433 cases, only 118 resulted in more than one day away from work,

and only six required some form of hospitalization.

No new anthrax vaccine is currently being produced because the sole

manufacturer of the vaccine, a laboratory once operated by the state of

Michigan, was sold to a private company, which had financial problems, and

has not yet been certified by the FDA.

Pentagon officials hope the new company, Bioport, will receive final FDA

certification by next month and begin producing new batches of the vaccine

by the end of the year.

So far, about 19 percent of the 2.4 million active-duty and reserve troops

have been given at least one of the series of anthrax vaccine shots that

must be administered to achieve full protection against the disease.

CNN Military Affairs Correspondent McIntyre contributed to this

report.

List Owner of Vaccinations and Vaccine Info

www.geocities.com/mom2q (my work in progress!)

Mom of two great kids who are vaccine free!